As the coronavirus death toll continues to rise, some have suggested that the approaching warmer spring weather in the northern hemisphere may slow or even stop the spread of the disease. US president Donald Trump echoed this, saying: “The heat, generally speaking, kills this kind of virus.” But is he right?
The idea that the approaching spring may stem the spread of the disease comes largely from a comparison with the flu. In many ways COVID-19 is like the flu – both spread in similar ways (respiratory secretions and contaminated surfaces) and both cause typically mild respiratory diseases that can develop into life-threatening pneumonia. But the transmissibility and severity of COVID-19 are much greater than the flu. And it isn’t clear if COVID-19 transmission will be affected by seasonal temperature variation.
For the flu, the start of spring causes a significant drop in the number of cases that persists until the return of colder temperatures in autumn. This seasonality of the flu is thought to be caused by the sensitivity of the virus to different climates and by seasonal changes in the human immune system and in our patterns of behaviour.
First, the flu virus appears to survive better in cold, dry weather with reduced ultraviolet light. Second, for many of us, the shorter winter days lead to reduced levels of vitamin D and melatonin, which can affect the performance of our immune system. Third, in the winter we spend more time with other people, indoors and in closer proximity, increasing opportunities for the virus to spread.
Comparing other coronavirus outbreaks
How then would these factors affect coronavirus transmission? It is not clear what effect temperature and humidity have on the coronavirus itself, nor on its transmission. Some other coronaviruses are seasonal, causing common colds in the winter months.
The 2002-2003 Sars epidemic also began in the northern hemisphere winter and ended in July 2003 with a small resurgence in cases in the following winter. But Sars cases peaked in the warmer month of May, and the end of the epidemic in July may simply reflect the time required for virus containment, rather than an effect of the summer weather on virus transmission. Also, the related Mers coronavirus is primarily transmitted in hot countries.
Returning to the comparison with the flu, the 2009-2010 influenza virus pandemic began in the spring, increased in strength over the spring and summer and peaked the following winter. This suggests that in a pandemic, the high number of cases in many countries around the world could enable continued transmission of the virus throughout the summer, overcoming any seasonal variability that would be seen in smaller epidemics. While the WHO has not yet declared a COVID-19 pandemic, many experts believe we are rapidly approaching the pandemic stage.
So the approaching warmer weather may reduce viral transmission in the northern hemisphere (while potentially increasing transmission in the coming southern hemisphere winter), but it is highly unlikely that the weather itself will end this growing epidemic.


Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Why the future of marijuana legalization remains hazy despite high public support
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
The four types of dementia most people don’t know exist
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 



